SMALL CELL CARCINOMA OF THE BLADDER
Clinical trials for SMALL CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: drug cocktail targets tough tumors
Disease control Recruiting nowThis study tests whether a combination of two cancer drugs—sacituzumab govitecan and atezolizumab—can shrink or control rare tumors of the bladder, kidney, ureters, and penis. About 60 adults with advanced or spreading cancers will receive the drugs through an IV. The goal is to …
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
New drug combo targets rare bladder cancer in phase 2 trial
Disease control Recruiting nowThis study tests two cancer drugs, lurbinectedin and avelumab, in people with a rare and aggressive type of bladder cancer (small cell carcinoma). The goal is to see if these drugs can shrink tumors or slow the disease. Participants receive treatment every 3 weeks for up to 10 ye…
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:51 UTC